Table 3.
Time-to-Onset Analysis for Signals with Efgartigimod Alfa
| Drugname | Weibull Distribution | Failure Type | ||||||
|---|---|---|---|---|---|---|---|---|
| Case Reports | TTO (Days) | Scale Parameter | Shape Parameter | |||||
| n | Median(d) (IQR) | Min–max | α | 95% CI | β | 95% CI | ||
| Efgartigimod alfa | 844 | 101.5(27–260) | 1–803 | 153.33 | 140.15–166.51 | 0.83 | 0.78–0.87 | Early failure |
Abbreviations: TTO, Time-to-onset; n, number of cases with available time-to-onset; IQR, interquartile range; CI, confidence interval; d, days; α, Scale parameter; β, Shape parameter.